SARS-CoV-2 seroprevalence and cross-variant antibody neutralization in cats, United Kingdom

Authors: Tyson, Grace B. ;

Jones, Sarah ;

Logan, Nicola;

McDonald, Michael;

Marshall, Leigh;

Murcia, Pablo R. ;

Willett, Brian J. ;

Weir, William;

Hosie, Margaret J.

Source: Emerging Infectious Diseases

Full text

: https://doi.org/10.3201/eid2906.221755

Abstract

Anthropogenic transmission of SARS-CoV-2 to pet cats highlights the importance of monitoring felids for exposure to circulating variants. We tested cats in the United Kingdom for SARS-CoV-2 antibodies; seroprevalence peaked during September 2021–February 2022. The variant-specific response in cats trailed circulating variants in humans, indicating multiple human-to-cat transmissions over a prolonged period.

Rights

This content is not covered by the Open Government Licence. Please see source record or item for information on rights and permissions.

Cite as

Tyson, G., Jones, S., Logan, N., McDonald, M., Marshall, L., Murcia, P., Willett, B., Weir, W. & Hosie, M. 2023, 'SARS-CoV-2 seroprevalence and cross-variant antibody neutralization in cats, United Kingdom', Emerging Infectious Diseases, 29(6). https://doi.org/10.3201/eid2906.221755

Downloadable citations

HTML BIB RIS

Identifiers

DOI: https://doi.org/10.3201/eid2906.221755

Repository URI: https://eprints.gla.ac.uk/295052/